Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
Text
Izervay™ (avacincaptad pegol) – Updated dosing
February 12, 2025 - Astellas announced the FDA approval of a label update for Izervay (avacincaptad pegol), removing the limitation that it could only be used for up to 12 months.